CARREFOUR SA (CA.PA)       17.93  +0.02 (+0.08%)

17.93  +0.02 (+0.08%)

FR0000120172 - Common Stock


Fundamental Rating

3

Taking everything into account, CA scores 3 out of 10 in our fundamental rating. CA was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CA have multiple concerns. While showing a medium growth rate, CA is valued expensive at the moment.




Profitability

Profitability Rating

2

The Piotroski-F score of CA is 7.00. This is a strong score and indicates good health and profitability for CA.

VS Industry

Valuation

Valuation Rating

3

With a Price/Earnings Ratio of 11.00, the valuation of CA can be described as very reasonable.
With a Forward Price/Earnings Ratio of 10.36, the valuation of CA can be described as very reasonable.

CA's PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
With a price book ratio of 1.18, CA is valued correctly.
VS Industry

Growth

Growth Rating

5

The Earnings Per Share has grown by an nice 10.88% over the past year.
Looking at the last year, CA shows a quite strong growth in Revenue. The Revenue has grown by 15.79% in the last year.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The Earnings Per Share has been growing slightly by 9.62% on average over the past 5 years.

The Earnings Per Share is expected to grow by 6.36% on average over the next 5 years.
The Revenue has been growing slightly by 0.52% on average over the past 5 years.
CA is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 1.65% yearly.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS9.62% 8.68% 10.88% 6.19% 13.16% 14.07% 6.36%
Revenue0.52% 3.87% 15.79% 5.23% 4.71% 4.61% 1.65%

Health

Health Rating

2

CA has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for CA.
An Altman-Z score of 1.99 indicates that CA is not a great score, but indicates only limited risk for bankruptcy at the moment.

CA has a Current Ratio of 0.89. This is a bad value and indicates that CA is not financially healthy enough and could expect problems in meeting its short term obligations.
CA has a Quick Ratio of 0.89. This is a bad value and indicates that CA is not financially healthy enough and could expect problems in meeting its short term obligations.
VS Industry

Dividend

Dividend Rating

4

The dividend of CA is nicely growing with an annual growth rate of 34.53%!
28.19% of the earnings are spent on dividend by CA. This is a low number and sustainable payout ratio.
CA has a Yearly Dividend Yield of 3.00%. Purely for dividend investing, there may be better candidates out there.

CA's Dividend Yield is comparable with the S&P500 average which is at 2.60.
CA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

CARREFOUR SA17.93

EPA:CA (3/29/2023, 9:52:30 AM)+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.10B
Analysts77.69
Price Target20.09 (12.05%)
Dividend
Industry RankSector Rank
Dividend Yield 3%
Dividend Growth(5Y)34.53%
DP28.19%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.96%
Min EPS beat(2)4.96%
Max EPS beat(2)4.96%
EPS beat(4)1
Avg EPS beat(4)-4.03%
Min EPS beat(4)-13.03%
Max EPS beat(4)4.96%
Revenue beat(2)1
Avg Revenue beat(2)81.42%
Min Revenue beat(2)81.42%
Max Revenue beat(2)81.42%
Revenue beat(4)1
Avg Revenue beat(4)40.17%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)81.42%
PT rev (1m)-0.71%
PT rev (3m)-0.32%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.44%
EPS NY rev (3m)-4.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 11
Fwd PE 10.36
P/S 0.16
P/FCF 5.61
P/OCF 3.1
P/B 1.18
P/tB 15.11
EV/EBITDA 5.56
EPS(TTM)1.63
EY9.09%
EPS(NY)1.73
Fwd EY9.65%
FCF(TTM)3.2
FCFY17.84%
OCF(TTM)5.77
OCFY32.21%
SpS113.73
BVpS15.25
TBVpS1.19
PEG (NY)1.78
PEG (5Y)1.14
Profitability
Industry RankSector Rank
ROA 2.38%
ROE 12.1%
ROIC 6.27%
ROICexc 7.84%
ROICexgc 13.84%
OM 2.86%
PM 1.62%
GM 19.63%
ROICexgc(3y)14.11%
ROICexcg growth 3Y6.01%
ROICexcg growth 5Y4.86%
ROICexc(3y)7.96%
ROICexc growth 3Y3.91%
ROICexc growth 5Y3.4%
OM growth 3Y0.11%
OM growth 5Y2.79%
PM growth 3Y2.23%
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5Y-2.68%
F-Score7
Asset Turnover1.47
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 8.23
Debt/EBITDA 4.17
Cap/Depr 84.17%
Profit Quality 173.37%
Current Ratio 0.89
Quick Ratio 0.63
Altman-Z 1.99
F-Score7
WACC4.62%
ROIC/WACC3
Cap/Depr(3y)73.94%
Cap/Depr(5y)80.89%
Profit Quality(3y)219.24%
Profit Quality(5y)N/A
Growth
EPS 1Y10.88%
EPS 3Y8.68%
EPS 5Y9.62%
EPS growth Q2Q14.29%
EPS Next Y6.19%
EPS Next 2Y13.16%
EPS Next 3Y14.07%
EPS Next 5Y6.36%
Revenue growth 1Y15.79%
Revenue growth 3Y3.87%
Revenue growth 5Y0.52%
Revenue growth Q2Q15.79%
Revenue Next Year5.23%
Revenue Next 2Y4.71%
Revenue Next 3Y4.61%
Revenue Next 5Y1.65%
EBIT growth 1Y8.34%
EBIT growth 3Y3.99%
EBIT growth 5Y3.32%
EBIT Next Year110.51%
EBIT Next 3Y34.95%
EBIT Next 5Y25.42%
FCF growth 1Y16.38%
FCF growth 3Y15.37%
FCF growth 5Y38.12%
OCF growth 1Y15.24%
OCF growth 3Y9.12%
OCF growth 5Y8.21%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext